Use of Antiretroviral Therapy in Pregnancy and Association With Birth Outcome Among Women Living With HIV in Denmark

Antiretroviral therapy (ART) is recommended worldwide for all people with HIV, including pregnant women.^[1] As a result, an increasing number of women living with HIV (WLWH) will either conceive or start treatment during pregnancy. The success of ART in combination with changing recommendations has resulted in a decreased risk of perinatal transmission to < 1% in Denmark and other high-income countries,^[2,3] leading to a growing population of HIV-exposed, uninfected (HEU) children.^[4] From a treatment perspective, pregnant women are a special population, largely because of the opportunity to prevent perinatal transmission of HIV and the need to consider the safety of the women themselves and their exposed foetuses and children.^[5]